EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.8.2.1 | Urinary Bladder Neoplasms |
26854433 |
Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolizing enzymes. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 2.8.2.1 | Urinary Bladder Neoplasms |
28589969 |
Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.8.2.1 | Urinary Bladder Neoplasms |
34055078 |
Expression and prognostic value of SULT1A2 in bladder cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
4 |
| 2.8.2.1 | Urogenital Neoplasms |
18854828 |
Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
3
3
2 |
| 2.8.2.1 | Vaccinia |
32798464 |
PXR phosphorylated at Ser350 transduces a glucose signal to repress the estrogen sulfotransferase gene in human liver cells and fasting signal in mouse livers. |
ongoing research
unassigned |
3
0 |
| 2.8.2.1 | Xeroderma Pigmentosum |
30042310 |
Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
3
1
0 |
